Product
Sofosbuvir/Daclatasvir
1 clinical trial
1 indication
Indication
Hepatitis C Virus InfectionClinical trial
Pilot Therapeutic Study of DAA Treatment for Children and Adolescents With Active HCV Infection in CambodiaStatus: Recruiting, Estimated PCD: 2024-12-01